S tr a t egy During the y e ar the C ompan y c on tinued t o f ocus on achie ving goals pr e viously outlined in the fv e y e ar s tr a t egic plan with t es ting a t its c or e T his me ans no t only building and e xpanding our highly suc c es s ful e xis ting busines ses but also de v eloping oper a tional e f fcienc y and inno v a tion and t echnology in non c y clical sec t ors o f the indus try During the y e ar the C ompan y carried out se v er al bolt on and s tr a t egic ac quisitions t o help sus t ain gr o w th o v er the longer t erm pr edomina t ely in the f ood and pharmac eutical t es ting sec t ors Ac quisitions included T ruesdail and BioScr een in the US A L ab f or in Br a zil F elsilab in It aly and M arrs in Chile T he C ompan y is positioned t o t ak e adv an t age o f oppor tunities in these sec t ors during FY2020 pr o vided the y ar e c omplemen t ary t o our e xis ting busines ses and c onsis t en t with the Gr oup s purpose and s tr a t egy P eople and C ultur e P eople and cultur e ar e c en tr al t o ALS s suc c es s During the y e ar the C ompan y again r ol led out its global emplo y ee sen timen t surv e y GlobALS a y which al lo w ed s t a f f t o pr o vide impor t an t f eed back on the s t a tus o f ALS cultur e T he surv e y w as e xtr emely w el l r ec eiv ed b y s t a f f with high le v els o f par ticipa tion and positiv e and c ons truc tiv e f eed back which wil l suppor t de v elopmen t o f a mor e pr oduc tiv e w orkplac e aligned t o ALS busines s priorities W e c on tinue t o f ocus on emplo y ee engagemen t t o a ttr ac t and r e t ain t alen t ed emplo y ees ALS has made pr ogr es s on incr e asing the r epr esen t a tion o f w omen in our senior le adership pipelines with f emale r ecruitmen t in our pr o f es sional r anks again e x c eeding 50 per c en t Sus t ainabilit y ALS is dedica t ed t o oper a ting in a r esponsible and sus t ain able manner Our c ommitmen t and pr ogr es s in the ar e as o f s a f e t y en vir onmen t c ommunit y and people ar e discus sed in the 2019 Sus t ainabilit y R epor t loca t ed on the C ompan y s w ebsit e a t alsglobalc om sus t ainabilit y He alth and S a f e t y T he C ompan y is c ommitt ed t o pr o viding a s a f e he alth y and secur e w ork en vir onmen t f or its emplo y ees In the fnancial y e ar ended 31 M ar ch 2019 the C ompan y r ec or ded its bes t s a f e t y per f ormanc e on r ec or d with a L os t Time Injury F r equenc y Ra t e LITFR o f 073 per mil lion hours w ork ed c ompar ed t o the pr e vious y e ar s fgur e o f 10 T his r epr esen ts a his t orical r ec or d lo w f or ALS E qual ly ple asing is the decr e ase in the T o t al R ec or dable Inciden t F r equenc y Ra t e TRIFR which me asur es inciden ts o f les ser harm fr om 3 t o 18 per mil lion hours w ork ed Despit e these impr o v ed r esults the busines s wil l c on tinue t o s triv e t o impr o v e on our s a f e t y c ommitmen t and discipline W e wil l r emain vigilan t acr os s al l our oper a tions t o ensur e e v ery one goes home fr ee fr om injury Outlook T he C ompan y r emains f ocused on being r e ady t o t ak e adv an t age o f futur e oppor tunities b y t ar ge ting or ganic and ac quir ed gr o w th in the mor e s t able en vir onmen t al f ood and pharmac eutical sec t ors and b y main t aining its as se ts mark e t shar e and r eput a tion in the mor e c y clical C ommodities and Indus trial divisions in or der t o c on tinue r esponding quickly as those mark e ts e v olv e Final ly w e w ould lik e t o ackno wledge the signifcan t c on tribution o f al l ALS emplo y ees t o the C ompan y s r esults and thank them f or their dedica tion and c ommitmen t o v er the pas t y e ar Bruc e P hil lips Chairman Ra j Nar an M anaging Dir ec t or and CE O 7 ALS LIMITED AND IT S SUBSIDIARIES A NNU AL F INANCIAL R EPOR T F OR THE Y EAR E NDED 31 M AR CH 2019 C HAIRMAN S AND CE O S REPOR T